Eltoukhy Helmy 4

4 · Guardant Health, Inc. · Filed Jul 2, 2025

Form 4

Period: 2025-06-30

DirectorCo-Chief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2025-07-01+23,997→ 2,435,661 total
Tax Payment
Common Stock
2025-06-30$52.04/sh−2,441$127,030→ 2,411,664 total
Exercise/Conversion
Restricted Stock Units
2025-06-30−4,815→ 9,629 total
Exercise: $0.00→ Common Stock (4,815 underlying)
Exercise/Conversion
Common Stock
2025-06-30+4,815→ 2,414,105 total
Exercise/Conversion
Restricted Stock Units
2025-07-01−23,997→ 143,983 total
Exercise: $0.00→ Common Stock (23,997 underlying)
Tax Payment
Common Stock
2025-07-01$50.71/sh−12,162$616,735→ 2,423,499 total

Footnotes (4)

[F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
[F2]This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
[F3]Not applicable for Restricted Stock Units.
[F4]This restricted stock unit award vested with respect to 1/3 of the shares on January 1, 2025. The remaining shares vest quarterly for the remaining twenty-four months.

Documents

1 file